Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
C4 Therapeutics, Inc. - Common Stock
(NQ:
CCCC
)
6.640
+0.580 (+9.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about C4 Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
December 13, 2023
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74....
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 13, 2023
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via
Benzinga
Expert Ratings for C4 Therapeutics
November 03, 2023
Via
Benzinga
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet
December 13, 2023
U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose,...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
C4 Therapeutics Inc. (NASDAQ: CCCC) is One of Wednesday Morning’s Most Active Stocks
December 13, 2023
Via
Investor Brand Network
US Stocks Mixed; Producer Prices Unchanged For November
December 13, 2023
U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
C4 Therapeutics Stock Is Surging Wednesday: What's Going On?
December 13, 2023
C4 Therapeutics Inc (NASDAQ: CCCC) shares are trading higher Wednesday after the company presented data from a Phase 1 trial for the p
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 13, 2023
Via
Benzinga
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 13, 2023
Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape...
Via
Benzinga
Exposures
Product Safety
D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
December 13, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 13, 2023
Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!
Via
InvestorPlace
C4 Therapeutics Announces Positive Data from CFT7455 Phase 1 Trial in Relapsed/Refractory Multiple Myeloma
December 12, 2023
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
Crude Oil Down 4%; Aditxt Shares Spike Higher
December 12, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday. The Dow traded up 0.32% to 36,520.57 while the NASDAQ rose 0.46% to 14,498.23. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 12, 2023
Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 12, 2023
Via
Benzinga
Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results
December 12, 2023
U.S. stocks turned higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.35% to 36,533.63 while the NASDAQ rose 0.16% to 14,455.15 The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Aditxt (ADTX) Stock Up 58% Today?
December 12, 2023
Aditxt stock is up on Tuesday as investors in ADTX shares react to the company announcing plans to acquire Evofem Biosciences.
Via
InvestorPlace
EGLE Stock Pops as Star Bulk Buys Eagle Bulk for $500 Million
December 12, 2023
Eagle Bulk Shipping stock is climbing higher on Tuesday after EGLE investors learned of a merger agreement with Star Bulk Carriers.
Via
InvestorPlace
Why Is C4 Therapeutics (CCCC) Stock Up 72% Today?
December 12, 2023
C4 Therapeutics stock is rising higher on Tuesday as investors in CCCC shares celebrate a new collaboration agreement with Merck.
Via
InvestorPlace
US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November
December 12, 2023
U.S. stocks traded slightly lower this morning, following the release of inflation data on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 36,389.01 while the NASDAQ fell...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Is Cancer-Focused C4 Therapeutics Stock Soaring Today?
December 12, 2023
C4 Therapeutics Inc (NASDAQ: CCCC) has entered into an exclusive license and collaboration agreement with Merck & Co Inc (NYSE: MRK) to develop degrader-antibody conjugates (DACs), an emerging modality...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 12, 2023
Via
Benzinga
C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degrader-Antibody Conjugates (DACs)
December 12, 2023
Initial Focus on One Oncology Target, Exclusive to Collaboration; Merck has Option for Three Additional Targets
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
C4 Therapeutics to Host Webcast to Present New Dose Escalation Data from CFT7455 Phase 1 Study in Relapsed/Refractory Multiple Myeloma
November 28, 2023
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
November 20, 2023
Owen Hughes, Accomplished Life Sciences Executive with Deep Experience Across Investing, Operations and Governance, Appointed as Independent Member of the Board of Directors
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 01, 2023
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 23, 2023
Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 23, 2023
Via
Benzinga
C4 Therapeutics Announces Upcoming Data Presentations for CFT8634, an Orally Bioavailable BiDAC™ Degrader in Development for Synovial Sarcoma and SMARCB1-Null Tumors, and CFT7455, an Orally Bioavailable MonoDAC™ Degrader in Development for Multiple
October 11, 2023
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.